Speaker:
DR. William E. Schreiber, MD Professor, Dept. of Pathology & Laboratory Medicine The University of British Columbia.
Dr. William E. (Wes) Schreiber earned an MD degree from Baylor College of Medicine and completed a residency in clinical pathology at the University of Washington. He was a consultant pathologist at Vancouver General Hospital for more than 30 years, with service responsibilities in the broad area of clinical chemistry. He was also medical director of the Provincial Toxicology Center for 10 years, which provides both forensic and clinical toxicology services for the province of British Columbia.
He recently retired from LifeLabs after spending 6 years as the Clinical Director of Chemistry. At UBC, Dr. Schreiber committed a large part of his career to the education of medical students, residents and colleagues. He directed the medical biochemistry residency program for 10 years and served as associate dean for undergraduate education at UBC from 1999-2002. He has received a number of teaching awards from students and peers, as well as recognition from professional organizations for contributions to continuing medical education.
Dr. Schreiber served as president of the American Society for Clinical Pathology (ASCP), the largest pathology organization in North America, in 2016-17.
Overview:
This presentation will review three phases of my career in laboratory medicine:
- Discovery of mutations causing acute intermittent porphyria and their translation into diagnostic tests
- Leadership of a forensic toxicology laboratory
- Role as a clinical consultant for a large outpatient laboratory
Objectives:
At the conclusion of this session, participants will be able to:
- Explain how mutation analysis is used to identify carriers for single gene disorders
- List key differences between clinical and post-mortem toxicology
- Describe the type of consultations needed in academic hospital s vs. community practice